Related Experiment Video
Updated: Mar 20, 2026

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples
Published on: May 10, 2015
Deubiquitinases and cancer: A snapshot
Nishant Singh1, Anuradha Bharara Singh2
1Department of Biological Sciences, Cleveland State University, Cleveland, OH 44115, USA.
Abstract:
Ubiquitination is the vital system for controlling protein degradation and regulation of basic cellular processes. Deubiquitinases (DUBs) are emerging as an important regulator of several pathways related to cancer and other diseases. Their ability to detach ubiquitin from the target substrate and regulation of signaling makes it potential target to treat cancer and other fatal diseases. In the current review, we are trying to summarize deubiquitination, and their role in cancer and potential small molecules DUBs inhibitors which can be used as drugs for cancer treatment.
Insights
Deubiquitinases (DUBs) regulate protein degradation and cellular processes. This review summarizes DUBs
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ubiquitination controls protein degradation and cellular processes.
- Deubiquitinases (DUBs) are key regulators of ubiquitination.
- Dysregulation of DUBs is implicated in cancer and other diseases.
Purpose of the Study:
- To review the process of deubiquitination.
- To summarize the role of DUBs in cancer development.
- To explore small molecule DUB inhibitors as potential cancer therapeutics.
Main Methods:
- Literature review of scientific publications.
- Analysis of DUBs' enzymatic activity and regulatory functions.
- Examination of preclinical and clinical studies on DUB inhibitors.
Main Results:
- DUBs play critical roles in diverse cellular signaling pathways.
- Aberrant DUB activity contributes to oncogenesis.
- Several small molecule DUB inhibitors show promise in cancer treatment.
Conclusions:
- Deubiquitination is a crucial regulatory mechanism.
- Targeting DUBs offers a viable strategy for cancer therapy.
- Further research into DUB inhibitors is warranted for drug development.
More Related Videos
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
11:36In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....